Correlation Between MoonLake Immunotherapeuti and Cyteir Therapeutics

Can any of the company-specific risk be diversified away by investing in both MoonLake Immunotherapeuti and Cyteir Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MoonLake Immunotherapeuti and Cyteir Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MoonLake Immunotherapeutics and Cyteir Therapeutics, you can compare the effects of market volatilities on MoonLake Immunotherapeuti and Cyteir Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MoonLake Immunotherapeuti with a short position of Cyteir Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MoonLake Immunotherapeuti and Cyteir Therapeutics.

Diversification Opportunities for MoonLake Immunotherapeuti and Cyteir Therapeutics

0.38

Correlation Coefficient

MoonLake Immunotherapeuti  Cyteir Therapeutics

Weak diversification

The 3 months correlation between MoonLake and Cyteir is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding MoonLake Immunotherapeutics and Cyteir Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyteir Therapeutics and MoonLake Immunotherapeuti is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MoonLake Immunotherapeutics are associated (or correlated) with Cyteir Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyteir Therapeutics has no effect on the direction of MoonLake Immunotherapeuti i.e., MoonLake Immunotherapeuti and Cyteir Therapeutics go up and down completely randomly.

Pair Corralation between MoonLake Immunotherapeuti and Cyteir Therapeutics

If you would invest  4,631  in MoonLake Immunotherapeutics on September 3, 2024 and sell it today you would earn a total of  812.00  from holding MoonLake Immunotherapeutics or generate 17.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	1.56%
Values	Daily Returns

MoonLake Immunotherapeutics  vs.  Cyteir Therapeutics

MoonLake Immunotherapeuti

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in MoonLake Immunotherapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, MoonLake Immunotherapeuti showed solid returns over the last few months and may actually be approaching a breakup point.

Cyteir Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cyteir Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Cyteir Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with MoonLake Immunotherapeuti and Cyteir Therapeutics

The main advantage of trading using opposite MoonLake Immunotherapeuti and Cyteir Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MoonLake Immunotherapeuti position performs unexpectedly, Cyteir Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyteir Therapeutics will offset losses from the drop in Cyteir Therapeutics' long position.

The idea behind MoonLake Immunotherapeutics and Cyteir Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.